Abstract
We studied whether pretreatment of U-251 MG human brain tumor cells with the polyamine analog 1,19-bis-(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4) affected the cytotoxicity of the topoisomerase II inhibitor etoposide. We found that BE-4-4-4-4 protected cells from the cytotoxic effects of etoposide. Possible mechanisms for this protection may be related to enhanced DNA-nuclear matrix association in analog-treated cells.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 975-980 |
| Number of pages | 6 |
| Journal | Cellular and molecular biology (Noisy-le-Grand, France) |
| Volume | 40 |
| Issue number | 7 |
| State | Published - Nov 1994 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology
- Cell Biology